SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study
Go back to SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study| (NASDAQ: SOPH) | Delayed: 7.54 +0.04 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.50 | 52 Week High | $ | |||
| Open | $7.50 | 52 Week Low | $ | |||
| Day High | $7.65 | P/E | N/A | |||
| Day Low | $7.46 | EPS | $ | |||
| Volume | 20,980 | |||||
